LifePoint Hospitals Announces Extension of Consent Solicitation Relating to Its 6.625% Senior Notes Due 2020 (CUSIP No. 53219L AK5)
BRENTWOOD, Tenn.--(BUSINESS WIRE)-- LifePoint Hospitals, Inc. (NAS: LPNT) announced today that it is extending the expiration date of its previously announced consent solicitation (the "Consent Solicitation") seeking consents from holders of its $400 million outstanding principal amount of 6.625% Senior Notes due 2020 (the "Notes") for amendments to certain provisions of the indenture governing the Notes.
The Consent Solicitation, which was previously scheduled to expire at 5:00 p.m., New York City time, on August 20, 2013, will be extended to 5:00 p.m., New York City time, on August 21, 2013, unless further extended or terminated by the Company.
All other terms and conditions of the Consent Solicitation, as set forth in the Consent Solicitation Statement dated July 30, 2013 (the "Consent Solicitation Statement"), remain the same.
Copies of the Consent Solicitation Statement and the consent form may be obtained by holders of the Notes from the Information and Tabulation Agent for the Consent Solicitation, D.F. King & Co., Inc., at (800) 949-2583 (toll-free), (212) 269-5550 (collect) or by email: firstname.lastname@example.org.
Barclays Capital Inc. is the Solicitation Agent for the Consent Solicitation. Questions may be directed to Barclays Capital Inc. at (800) 438-3242 (toll-free) or (212) 528-7581 (collect).
About LifePoint Hospitals
LifePoint Hospitals, Inc. is a leading hospital company focused on providing quality healthcare services close to home. Through its subsidiaries, LifePoint operates 57 hospital campuses in 20 states. With a mission of "Making Communities Healthier®," LifePoint is the sole community hospital provider in the majority of the communities it serves. More information about the Company, which is headquartered in Brentwood, Tennessee, can be found on its website, www.LifePointHospitals.com. All references to "LifePoint," "LifePoint Hospitals," or the "Company" used in this release refer to LifePoint Hospitals, Inc. or its affiliates.
In addition to historical information, this report may contain certain statements that constitute "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995.Such forward-looking statements, together with other statements that are not historical, are based on management's current expectations and involve known and unknown risks, uncertainties, contingencies and other factors that could cause results, performance or achievements to differ materially from those stated.The most significant of these risks and uncertainties are described in the Company's Form 10-K, Form 10-Q and Form 8-K reports filed with the Securities and Exchange Commission.Should one or more of these risks or uncertainties materialize or should underlying assumptions prove incorrect, the Company's actual results, performance or achievements could differ materially from those expressed in, or implied by, such forward-looking statements.Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date hereof.Except as otherwise required by law, the Company does not undertake any obligation to publicly release any revisions to these forward-looking statements to reflect events or circumstances after the date hereof or to reflect the occurrence of unanticipated events.
LifePoint Hospitals, Inc.
Jeff Sherman, 615-372-8501
Executive Vice President and Chief Financial Officer
KEYWORDS: United States North America Tennessee
The article LifePoint Hospitals Announces Extension of Consent Solicitation Relating to Its 6.625% Senior Notes Due 2020 (CUSIP No. 53219L AK5) originally appeared on Fool.com.
Try any of our Foolish newsletter services free for 30 days. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.
Copyright © 1995 - 2013 The Motley Fool, LLC. All rights reserved. The Motley Fool has a disclosure policy.